Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengguo Xing

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Journal of Cellular Biochemistry|October 9, 2015
Autophagy-Mediated Degradation of IAPs and c-FLIP(L) Potentiates Apoptosis Induced by Combination of TRAIL and Chal-24Jennings Xu, Xiuling Xu, Shaoqing Shi, et al.
Carcinogenesis|May 16, 2026
Assessing the Physiological Relevance of the Bioactivation of Tobacco Specific Carcinogen NNK and its Metabolite NNAL: Quantitative Analyses of Hydrolysis Products from Their Protein Adducts under Different Carcinogen Exposure ConditionsBreanne Freeman, Tengfei Bian, Gujie Xu, et al.
Implementation Research and Practice|March 13, 2023
Implementation strategies for integrating tobacco cessation treatment in cancer care: A qualitative studyJennifer H LeLaurin, Ryan P Theis, Jesse Dallery, et al.
BMC Complementary Medicine and Therapies|December 21, 2024
The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and insomnia: study protocol for a randomized clinical trialChengguo Xing, John Malaty, Melissa Bou Malham, et al.
Trials|November 4, 2015
Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trialKaren M Savage, Con K Stough, Gerard J Byrne, et al.
Redox Biology|April 2, 2025
Design of anti-depressant phosphodiester amino acidic Keap1-Nrf2 protein-protein interaction inhibitorsYi Sun, Jue Wang, Wenxin Ding, et al.
Carcinogenesis|July 24, 2014
Dihydromethysticin from kava blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis and differentially reduces DNA damage in A/J miceSreekanth C Narayanapillai, Silvia Balbo, Pablo Leitzman, et al.
Molecular Pharmacology|June 30, 2009
Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondriaDavid Hermanson, Sadiya N Addo, Anna A Bajer, et al.
International Journal of Molecular Sciences|June 10, 2023
Opportunities and Challenges of Kava in Lung Cancer PreventionBreanne Freeman, Jessica Mamallapalli, Tengfei Bian, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2020
The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active SmokersYi Wang, Sreekanth C Narayanapillai, Katelyn M Tessier, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Journal of Cellular Biochemistry|October 9, 2015
Autophagy-Mediated Degradation of IAPs and c-FLIP(L) Potentiates Apoptosis Induced by Combination of TRAIL and Chal-24Jennings Xu, Xiuling Xu, Shaoqing Shi, et al.
Carcinogenesis|May 16, 2026
Assessing the Physiological Relevance of the Bioactivation of Tobacco Specific Carcinogen NNK and its Metabolite NNAL: Quantitative Analyses of Hydrolysis Products from Their Protein Adducts under Different Carcinogen Exposure ConditionsBreanne Freeman, Tengfei Bian, Gujie Xu, et al.
Implementation Research and Practice|March 13, 2023
Implementation strategies for integrating tobacco cessation treatment in cancer care: A qualitative studyJennifer H LeLaurin, Ryan P Theis, Jesse Dallery, et al.
BMC Complementary Medicine and Therapies|December 21, 2024
The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and insomnia: study protocol for a randomized clinical trialChengguo Xing, John Malaty, Melissa Bou Malham, et al.
Trials|November 4, 2015
Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trialKaren M Savage, Con K Stough, Gerard J Byrne, et al.
Redox Biology|April 2, 2025
Design of anti-depressant phosphodiester amino acidic Keap1-Nrf2 protein-protein interaction inhibitorsYi Sun, Jue Wang, Wenxin Ding, et al.
Carcinogenesis|July 24, 2014
Dihydromethysticin from kava blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis and differentially reduces DNA damage in A/J miceSreekanth C Narayanapillai, Silvia Balbo, Pablo Leitzman, et al.
Molecular Pharmacology|June 30, 2009
Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondriaDavid Hermanson, Sadiya N Addo, Anna A Bajer, et al.
International Journal of Molecular Sciences|June 10, 2023
Opportunities and Challenges of Kava in Lung Cancer PreventionBreanne Freeman, Jessica Mamallapalli, Tengfei Bian, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2020
The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active SmokersYi Wang, Sreekanth C Narayanapillai, Katelyn M Tessier, et al.
Pageof 12